Puenpatom A - Search Results

1

Efficacy and safety of elbasvir/grazoprevir in treatment-naive Chinese adults with hepatitis C virus infection: A randomized trial.

Wei L, Jia JD, Duan ZP, Wang FS, Niu JQ, Xie W, Huang WX, Zhang MX, Huang Y, Wang MR, Wu SM, Zhao YR, Jia ZS, Zhao XM, Mu SM, Liang LW, Wang Z, Puenpatom A, Hwang P, Robertson MN, Ingravallo P, Asante-Appiah E, Wei B, Evans B, Hanna GJ, Talwani R. Wei L, et al. Among authors: puenpatom a. JGH Open. 2020 Jul 15;4(6):1065-1073. doi: 10.1002/jgh3.12387. eCollection 2020 Dec. JGH Open. 2020. PMID: 33319038 Free PMC article.

2

Effectiveness of Elbasvir/Grazoprevir in patients with hepatitis C virus genotype 1 infection and chronic kidney disease in the United States veterans population.

Choi DT, Puenpatom A, Yu X, Erickson KF, Kanwal F, El-Serag HB, Kramer JR. Choi DT, et al. Among authors: puenpatom a. Antiviral Res. 2020 Feb;174:104698. doi: 10.1016/j.antiviral.2019.104698. Epub 2019 Dec 17. Antiviral Res. 2020. PMID: 31862503 Free PMC article.

3

Effectiveness of Elbasvir/Grazoprevir in US Veterans with Chronic Hepatitis C Virus Genotype 1b Infection.

Puenpatom A, Cao Y, Yu X, Kanwal F, El-Serag HB, Kramer JR. Puenpatom A, et al. Infect Dis Ther. 2020 Jun;9(2):355-365. doi: 10.1007/s40121-020-00293-7. Epub 2020 Apr 15. Infect Dis Ther. 2020. PMID: 32297307 Free PMC article.

4

Treatment of hepatitis C virus infection in people with opioid use disorder: a real-world study of elbasvir/grazoprevir in a US Department of Veterans Affairs population.

Kramer JR, Puenpatom A, Cao Y, Yu X, El-Serag HB, Kanwal F. Kramer JR, et al. Among authors: puenpatom a. Am J Drug Alcohol Abuse. 2022 Jul 4;48(4):445-453. doi: 10.1080/00952990.2021.1983821. Epub 2022 Jan 25. Am J Drug Alcohol Abuse. 2022. PMID: 35077656

5

Real-world effectiveness of elbasvir/grazoprevir In HCV-infected patients in the US veterans affairs healthcare system.

Kramer JR, Puenpatom A, Erickson KF, Cao Y, Smith D, El-Serag HB, Kanwal F. Kramer JR, et al. Among authors: puenpatom a. J Viral Hepat. 2018 Nov;25(11):1270-1279. doi: 10.1111/jvh.12937. Epub 2018 Jul 3. J Viral Hepat. 2018. PMID: 29851265 Free PMC article.

6

Initial uptake, time to treatment, and real-world effectiveness of all-oral direct-acting antivirals for hepatitis C virus infection in the United States: A retrospective cohort analysis.

Kwo PY, Puenpatom A, Zhang Z, Hui SL, Kelley AA, Muschi D. Kwo PY, et al. Among authors: puenpatom a. PLoS One. 2019 Aug 22;14(8):e0218759. doi: 10.1371/journal.pone.0218759. eCollection 2019. PLoS One. 2019. PMID: 31437170 Free PMC article.

7

Cost-Utility of All-Oral Direct-Acting Antiviral Regimens for the Treatment of Genotype 1 Chronic Hepatitis C Virus-Infected Patients in Hong Kong.

Yuen MF, Liu SH, Seto WK, Mak LY, Corman SL, Hsu DC, Lee MYK, Khan TK, Puenpatom A. Yuen MF, et al. Among authors: puenpatom a. Dig Dis Sci. 2021 Apr;66(4):1315-1326. doi: 10.1007/s10620-020-06281-8. Epub 2020 May 8. Dig Dis Sci. 2021. PMID: 32385703 Free PMC article.

8

Treatment persistence and colectomy-free outcomes in patients with ulcerative colitis receiving golimumab or adalimumab: a UK experience.

Hoque S, Puenpatom A, Boccaletti S, Green C, Black CM, Roberts J, Rajkovic I, Milligan G. Hoque S, et al. Among authors: puenpatom a. BMJ Open Gastroenterol. 2020 Nov;7(1):e000476. doi: 10.1136/bmjgast-2020-000476. BMJ Open Gastroenterol. 2020. PMID: 33199269 Free PMC article.

9

Dalgard O, Litwin AH, Shibolet O, Grebely J, Nahass R, Altice FL, Conway B, Gane EJ, Luetkemeyer AF, Peng CY, Iser D, Gendrano IN, Kelly MM, Haber BA, Platt H, Puenpatom A; CO-STAR Investigators. Dalgard O, et al. Among authors: puenpatom a. J Addict Dis. 2023 Jul-Sep;41(3):213-224. doi: 10.1080/10550887.2022.2088978. Epub 2022 Aug 3. J Addict Dis. 2023. PMID: 35920743 Clinical Trial.

10

The effects of sustained virological response to direct-acting anti-viral therapy on the risk of extrahepatic manifestations of hepatitis C infection.

El-Serag HB, Christie IC, Puenpatom A, Castillo D, Kanwal F, Kramer JR. El-Serag HB, et al. Among authors: puenpatom a. Aliment Pharmacol Ther. 2019 Jun;49(11):1442-1447. doi: 10.1111/apt.15240. Epub 2019 Apr 1. Aliment Pharmacol Ther. 2019. PMID: 30932218 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

31 results

Search Page